MedTrace Logo

Wearing Behavior and Eye Length Changes in Children With Myopia Wearing Myopia Control Spectacle Lenses

NCT07780851 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-08-24

No results posted yet for this study

Summary

The goal of this clinical trial is to learn how children with myopia aged 8 to 15 years move their eyes and heads during near-vision tasks while wearing different spectacle lenses, and if wearing myopia control spectacle lenses for one month is related to change in eye length (axial length). The main questions it aims to answer are:

1. How do eye gaze position and head movement patterns change when children wear the commercially available myopia control spectacle lenses compared with single-vision spectacle lenses?
2. Does wearing myopia control spectacle lenses for one month lead to short-term changes in axial length?

This study compares commercially available myopia control spectacle lenses with single-vision spectacle lenses to evaluate differences in eye gaze position, head movement patterns, and axial length.

Participants will:

* Attend three study visits at the Singapore Polytechnic Optometry Centre.
* Wear the assigned study spectacles while performing near-vision tasks.
* Have video recordings of their face collected, to evaluate eye and head movements, during the near-vision tasks.

Conditions

  • Myopia

Interventions

DEVICE

Single Vision Lens (SVL)

Standard, commercially available single vision spectacle lenses worn on-site during near vision task assessment at Visit 2 and Visit 3.

DEVICE

Myopia Control Lens (MCL)

Commercially available Stellest® spectacle lenses worn on-site during near vision task assessment at Visit 2 and Visit 3, and worn continuously for approximately 1 month between Visit 2 and Visit 3.

Sponsors & Collaborators

  • Essilor International

    lead INDUSTRY

Principal Investigators

  • Danny Sim · Singapore Polytechnic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
8 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-02
Primary Completion
2026-03-09
Completion
2026-03-23

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07780851 on ClinicalTrials.gov